New York: Researchers have identified a protein that is strongly associated with metastatic breast cancer and that could be a target for future therapies.
Metastatic breast cancer is cancer that has spread to other sites in the body, and the vast majority of breast cancer deaths occur in patients in whom cancer has metastasised.
The findings, published in the Journal of Clinical Investigation, suggest that high levels of the protein ZMYND8 could be correlated with poor survival in breast cancer patients.
Previous research had shown that breast cancer cells that are more aggressive in an oxygen-deprived, or hypoxic, environment.
A protein family called hypoxia-inducible factor (HIF) controls responses to hypoxia, switching on pathways that lead to cancer cell growth and spread.
“Our research shows that ZMYND8 is a regulator that activates hundreds of HIF-dependent oncogenes in breast cancer cells,” said Weibo Luo, Assistant Professor at University of Texas Southwestern Medical Center in the US.
Research with a mouse model of breast cancer showed that depletion of the protein blocks the growth of new blood vessels in tumours and leads to breast cancer cell death.
This work “reveals a possible molecular target for diagnosis and treatment of aggressive disease”, Luo said.zeenews
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022